314 related articles for article (PubMed ID: 33158306)
1. Optical Biosensors for the Detection of Rheumatoid Arthritis (RA) Biomarkers: A Comprehensive Review.
Imas JJ; Ruiz Zamarreño C; Zubiate P; Sanchez-Martín L; Campión J; Matías IR
Sensors (Basel); 2020 Nov; 20(21):. PubMed ID: 33158306
[TBL] [Abstract][Full Text] [Related]
2. CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis.
Myngbay A; Bexeitov Y; Adilbayeva A; Assylbekov Z; Yevstratenko BP; Aitzhanova RM; Matkarimov B; Adarichev VA; Kunz J
Front Immunol; 2019; 10():1353. PubMed ID: 31249576
[No Abstract] [Full Text] [Related]
3. Biomarkers in Rheumatoid Arthritis, what is new?
Gavrilă BI; Ciofu C; Stoica V
J Med Life; 2016; 9(2):144-8. PubMed ID: 27453744
[TBL] [Abstract][Full Text] [Related]
4. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
5. Anti-citrullinated protein antibodies suppress let-7a expression in monocytes from patients with rheumatoid arthritis and facilitate the inflammatory responses in rheumatoid arthritis.
Lai NS; Yu HC; Yu CL; Koo M; Huang HB; Lu MC
Immunobiology; 2015 Dec; 220(12):1351-8. PubMed ID: 26227320
[TBL] [Abstract][Full Text] [Related]
6. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
[TBL] [Abstract][Full Text] [Related]
7. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis.
Che Rahim MJ; Wan Mohamad WM; Saddki N; Taib H; Wan Abhamid WZ; Wong KK; Wan Ghazali WS
Malays J Pathol; 2019 Dec; 41(3):267-272. PubMed ID: 31901911
[TBL] [Abstract][Full Text] [Related]
9. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
[TBL] [Abstract][Full Text] [Related]
10. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
Front Immunol; 2018; 9():876. PubMed ID: 29740454
[TBL] [Abstract][Full Text] [Related]
11. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.
Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F
Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660
[TBL] [Abstract][Full Text] [Related]
12. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
[No Abstract] [Full Text] [Related]
13. Circulating microRNA-23b as a new biomarker for rheumatoid arthritis.
Liu X; Ni S; Li C; Xu N; Chen W; Wu M; van Wijnen AJ; Wang Y
Gene; 2019 Sep; 712():143911. PubMed ID: 31176730
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Shinkai Y; Kumagai Y; Ishigami A; Sumida T
Arthritis Res Ther; 2018 Apr; 20(1):66. PubMed ID: 29636082
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
Front Immunol; 2018; 9():2388. PubMed ID: 30420853
[TBL] [Abstract][Full Text] [Related]
16. Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis.
Ouboussad L; Hunt L; Hensor EMA; Nam JL; Barnes NA; Emery P; McDermott MF; Buch MH
Arthritis Res Ther; 2017 Dec; 19(1):288. PubMed ID: 29273071
[TBL] [Abstract][Full Text] [Related]
17. Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.
Boer AC; Boonen A; van der Helm van Mil AHM
Arthritis Care Res (Hoboken); 2018 Jul; 70(7):987-996. PubMed ID: 29266813
[TBL] [Abstract][Full Text] [Related]
18. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.
Martinez-Prat L; Nissen MJ; Lamacchia C; Bentow C; Cesana L; Roux-Lombard P; Gabay C; Mahler M
Front Immunol; 2018; 9():1113. PubMed ID: 29928272
[TBL] [Abstract][Full Text] [Related]
20. An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients.
Martínez-Estupiñán L; Hernández-Flórez D; Janta I; Ovalles-Bonilla JG; Nieto JC; González-Fernández CM; Del Río T; Monteagudo I; López-Longo FJ; Naredo E; Valor L
Clin Exp Rheumatol; 2018; 36(1):88-93. PubMed ID: 28850020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
